TOVX Theriva Biologics, Inc. Net earnings per share growth this year

TOVX (Theriva Biologics, Inc.) - company brandmark

Theriva Biologics, Inc. (TOVX) is pursuing the expansion of its VCN-01 oncolytic drugs to combat solid tumors. The annual earnings per share trend reflects a dynamic where 88.00 serves as the current metric. Future company revenues will be based on royalties from partners for microbiome protection technologies. Currently, the business relies on existing liquidity to cover R&D expenses.

Theriva Biologics (TOVX): Net earnings per share growth this year from 04/28/2023 to 11/18/2026

Analytical breakdowns and data insights for company Theriva Corp (TOVX)

- current quotes and average value forecast:
Summary company analysis:TOVX (Theriva Biologics, Inc.)
Brand item of Synthetic Biologics

Investors view Theriva Biologics, Inc. (TOVX) as a high-risk asset with M&A potential driven by the development of VCN-01. This metric measures the year-over-year dynamics of net earnings per share, allowing for the tracking of capitalization rates without reporting delays. By analyzing the final annual EPS growth figure, one can assess the impact of clinical successes on the fundamental value of this biotechnology company.

Key competitors

IBRX - Expected net earnings per share growth this year|Earnings per share growth in current year immunocore.com|Net earnings per share growth this year januxrx.com (JANX)|Earnings per share growth in current year Arcus Biosciences Inc (RCUS)|Net earnings per share growth this year Zymeworks Corp ZYME|Tango Therapeutics Inc - Net earnings per share growth this year|Earnings growth in current year Iovance Corp IOVA|IMTX - Earnings per share growth in current year|XNCR (xencor.com) - Earnings per share growth this year|Compass Therapeutics Corp (CMPX) - Earnings per share growth in current year|Earnings per share growth rate in current year Replimune Corp (REPL)|Net earnings per share growth this year LYEL|IPHA - Net earnings per share change in current year|Net earnings per share growth this year PYXS (Pyxis Oncology, Inc.)|Net earnings per one share growth for the current year CGEN|Earnings growth in current year IOBT (IO Biotech)|Earnings per share increase in current year STRO|minktherapeutics.com - Earnings growth in current year|Earnings per share growth rate in current year Werewolf Therapeutics, Inc.|Immix (IMMX) - Earnings per share growth in current year|ALX Oncology Holdings - Earnings per share increase in current year|Earnings per share growth in current year Cue Biopharma|Earnings growth in current year pdsbiotech.com|Earnings per share growth in current year sonnetbio.com (SONN)|MAIA: Earnings per share trend in current year|Liminatus Pharma Inc. - Net earnings per share growth this year|LAVA Therapeutics N.V. (LVTX) - Earnings per share growth rate in current year|NXTC - Earnings per share growth in current year|LPTX: Earnings per share growth in current year|Intensity Therapeutics (INTS) - Earnings per share growth in current year|Earnings per share growth rate in current year Sensei Bio (SNSE)|GRTS (Gritstone bio) - Earnings growth in current year|KA (Kineta, Inc.) - Net earnings per one share growth for the current year|Earnings growth in current year NEXI|Turnstone Biologics Corp - Earnings per share growth this year|Earnings growth in current year VCNX (Vaccinex Inc)|Harpoon Therapeutics Corp (HARP) - Earnings per share growth rate in current year